glp-1 enhancer Integrating Receptor Agonists into Modern Stroke Prevention: Evidence, Mechanisms, and Clinical Consideration—A Narrative Review Designing GLP-1 delivery: structural perspectives

A common question is whether GLP-1 drugs cause cancer, since early animal studies suggested a risk of thyroid tumors

Body composition (BC) was assessed using various methods, most commonly bioelectrical impedance analysis (BIA), followed by dual-energy X-ray absorptiometry (DXA)

A Differentiated Next-Generation GLP Candidate SureNano Science is advancing GEP-44 as a patented, next-generation metabolic therapy intended to improve upon limitations associated with first-generation GLP-1 drugs, positioning this emerging microcap as a minnow among giants quickly transitioning through the FDA pathway

A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities behind the weight loss boom

Keep reading Published on: October 04, 2023 Six Steps to Reduce Your Cancer Risk By Wellstar Urologist Dr